H.B. Fuller to Acquire Advanced Medical Solutions for £715M with 35% Premium
FUL•H.B. Fuller will acquire Advanced Medical Solutions for £715 million including debt, paying 285 pence per share, a 35% premium to pre-offer levels. The deal is expected to close by end-2026 and deliver about $55 million in annual run-rate synergies by 2031, broadening its medical adhesives portfolio.
1. Deal Structure
H.B. Fuller agreed to purchase Advanced Medical Solutions in an all-cash transaction valuing the company at £715 million including debt. The offer of 285 pence per share represents a 35% premium to AMS’s closing price on May 20, just before the offer period commenced.
2. Strategic Rationale
This acquisition enhances H.B. Fuller’s position in the medical adhesives sector, targeting durable demand trends and high regulatory entry barriers. The deal expands the company’s geographic reach across the U.S., Europe and other key markets.
3. Expected Synergies and Financial Impact
The combination is projected to generate approximately $55 million in annual run-rate synergies by 2031, driven by cost efficiencies and cross-selling opportunities. Funding will be sourced from existing liquidity and debt facilities, with anticipated accretion to margins over time.
4. Timeline and Approvals
Closing is slated by the end of 2026, pending customary regulatory and shareholder approvals. AMS’s board unanimously recommended the offer, concluding a period of private equity interest that had failed to produce a final bid.
